The Instrument Tracking Data Goldmine

Hank Balch, founder and President of Beyond Clean, joined host Hilary Kennedy on ConCensis to discuss how instrument tracking data can be a resume goldmine in today’s sterile processing landscape. Balch has a long and extensive resume filled with of industry awards, blogs, social media prowess and conference speeches.

Balch started as a frontline technician in instrument reprocessing. He spoke about how his work in sterile processing changed after becoming a father, when he realized that when it comes to little ones going into surgery, “there is no margin for error.”

“The fatherhood piece is baked into everything I do,” said Balch. He described the industry as being very personal. When it comes to sterile processing, there has been a debate for many years about whether there should be greater background requirements since a higher education degree is not currently an entry-level requirement. Balch weighed both the advantages and disadvantages to this and the potential career opportunities it provides.

For Balch, he doesn’t think career experience is the only indicator of a good job candidate. “We want data that can say ‘I contributed this to the productivity and to the efficiency and to the safety of my department,’” said Balch. He cited total instruments processed and total trays assembled as indicators to look for to defray challenges in the recruiting process.

Balch also discussed how this data could positively impact issues with pay rate in the industry. Recent data has highlighted the significant impact of sterile processors, which is also helping to beef up resumes. “It’s the first step to begin this data-driven conversation at the HR level… that your resume can get to the top of the pile.”

Balch encourages employees to advocate for their departments to track instrument data if they are not already tracking it. “Now everyone in the department will be better positioned to be more competitive in the workplace or the industry as a whole because they can get access to their instrument data.”

Interested in learning more about Censis Technologies’ surgical asset management platform? Visit Censis.com.

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More